Satisfaction, utilisation and perceived benefit of individual psychosocial support for breast cancer patients—A randomised study of nurse versus psychologist interventions
“…This number is nearly twice as high as the corresponding number in the (age-matched) general population. This confirms previous findings and indicates the need for screening psychological distress in order to provide adequate psychological support for the women [24]. The severity of the psychological burden generally diminished over time.…”
Background/Aims: The aim of this study was to assess the course of anxiety and depression in cancer patients over time and to detect determinants of the changes in the scores. Patients and Method: Women with breast cancer and gynaecological cancer (n = 367) were tested at the beginning (T1) and at the end (T2) of treatment in the hospital, 6 months later (T3), and 12 months later (T4), using the Hospital Anxiety and Depression Scale (HADS). Results: Anxiety and depression were highest at the start of the stay in the hospital. More than half of the women are at least doubtful cases in at least one of the two HADS dimensions. The mean scores declined from T1 to T4. After 1 year, depression scores are similar to those of the general population, while anxiety scores remain elevated. The decline of the HADS scores depends on treatment, time since diagnosis, and education. Conclusions: Women receiving radio- or chemotherapy (compared with surgery only), with a long time since diagnosis, and with a low educational level are at high risk of maintaining high anxiety and depression scores over time.
“…This number is nearly twice as high as the corresponding number in the (age-matched) general population. This confirms previous findings and indicates the need for screening psychological distress in order to provide adequate psychological support for the women [24]. The severity of the psychological burden generally diminished over time.…”
Background/Aims: The aim of this study was to assess the course of anxiety and depression in cancer patients over time and to detect determinants of the changes in the scores. Patients and Method: Women with breast cancer and gynaecological cancer (n = 367) were tested at the beginning (T1) and at the end (T2) of treatment in the hospital, 6 months later (T3), and 12 months later (T4), using the Hospital Anxiety and Depression Scale (HADS). Results: Anxiety and depression were highest at the start of the stay in the hospital. More than half of the women are at least doubtful cases in at least one of the two HADS dimensions. The mean scores declined from T1 to T4. After 1 year, depression scores are similar to those of the general population, while anxiety scores remain elevated. The decline of the HADS scores depends on treatment, time since diagnosis, and education. Conclusions: Women receiving radio- or chemotherapy (compared with surgery only), with a long time since diagnosis, and with a low educational level are at high risk of maintaining high anxiety and depression scores over time.
“…patients go through, a period of relatively rapid improvement with regard to HRQOL, including emotional functioning, after diagnosis and medical treatment Glimelius, 1997, 1998;Arving et al, 2007). Thus, the measures used in this study seem to be capable of detecting statistically significant and clinically relevant improvements with regard to these aspects.…”
Section: Subscalesmentioning
confidence: 73%
“…However, it is still unclear whether individual or group support is more effective in relieving problems of anxiety and depression (Sheard and Maguire, 1999;Osborn et al, 2006). Different types of interventions have been evaluated in different diagnostic groups and at different times in the illness trajectory (Arving et al, 2007;May et al, 2008), which makes it difficult to assess the clinical value of the trial results. In addition, a majority of the studies include small samples, which jeopardises the possibilities of detecting small but clinically relevant differences between groups.…”
To compare the effectiveness of individual support, group rehabilitation and a combination of the two in improving health-related quality of life (HRQOL) and psychological well-being in cancer patients during 24 months after diagnosis, as compared with standard care (SC). Furthermore, to compare the study sample and a random sample of the Swedish population with regard to HRQOL. A total of 481 consecutive patients, newly diagnosed with cancer, were randomly assigned to one of the four alternatives. Data on HRQOL and psychological well-being were collected at baseline and after 3, 6, 12 and 24 months. The interventions did not improve HRQOL or psychological well-being, as compared with SC. At 3 months, the study sample reported an HRQOL comparable with the normal population. Many cancer patients are able to manage their cancer-related concerns with the support available from SC. However, it is reasonable to assume that the findings suffer from a lack of data from especially vulnerable patients and a possible Hawthorne effect. It cannot be concluded that cancer patients have no need for additional psychosocial interventions. Future projects should include screening and target interventions for those at risk for significant and prolonged psychological distress.
“…This encouraging situation is explained by extended multidisciplinary efforts to improve patient care including palliative chemotherapy (2), nutritional support (3,4), systemic antiinflammatory treatment, and pain treatment (4 -7), which are all founded on evidence-based medicine. Our earlier studies of host metabolism in response to progressive malignancy were usually carried out on hospitalized patients, in part due to the application of considerably invasive models (8 -10).…”
Purpose: To evaluate daily physical-rest activities in cancer patients losing weight in relation to disease progression. Experimental Design: Physical activity-rest rhythms were measured (ActiGraph, armband sensor from BodyMedia) in relation to body composition (dual-energy X-ray absorptiometry), energy metabolism, exercise capacity (walking test), and self-scored quality of life (SF-36, Hospital Anxiety and Depression Scale) in weight-losing outpatients with systemic cancer (71 F 2 years, n = 53). Well-nourished, age-matched, and previously hospitalized non^cancer patients served as controls (74 F 4 years, n = 8). Middle-aged healthy individuals were used as reference subjects (49 F 5 years, n = 23).Results: Quality of life was globally reduced in patients with cancer (P < 0.01), accompanied by significantly reduced spontaneous physical activity during both weekdays and weekends compared with reference subjects (P < 0.01). Spontaneous physical activity declined over time during follow-up in patients with cancer (P < 0.05). However, overall physical activity and the extent of sleep and bed-rest activities did not differ between patients with cancer and age-matched non^cancer patients. Spontaneous physical activity correlated weakly with maximum exercise capacity in univariate analysis (r = 0.41, P < 0.01). Multivariate analysis showed that spontaneous physical activity was related to weight loss, blood hemoglobin concentration, C-reactive protein, and to subjectively scored items of physical functioning and bodily pain (SF-36; P < 0.05-0.004). Anxiety and depression were not related to spontaneous physical activity. Patient survival was predicted only by weight loss and serum albumin levels (P < 0.01), although there was no such prediction for spontaneous physical activity. Conclusions: Daily physical-rest activities represent variables which probably reflect complex mental physiologic and metabolic interactions. Thus, activity-rest monitoring provides a new dimension in the evaluation of medical and drug interventions during palliative treatment of patients with cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.